Navigation Links
New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes
Date:4/23/2010

PARSIPPANY, N.J., April 23 /PRNewswire/ -- Results of a new study showed that Welchol® (colesevelam HCl) 3.75 g/d significantly improved lipid and glycemic measures in patients with high LDL cholesterol and prediabetes (impaired fasting glucose and/or impaired glucose tolerance).  The randomized, placebo-controlled, double-blind study was presented today at the American Association of Clinical Endocrinologists (AACE) 19th Annual Meeting and Clinical Congress in Boston.(1)  These data are consistent with previous studies that have shown Welchol to be safe and effective in lowering A1C, fasting plasma glucose and low-density lipoprotein cholesterol (LDL-C) in adult patients with type 2 diabetes.(2)

"These new findings are important because they provide valuable information on the effects of Welchol to significantly reduce LDL cholesterol, fasting plasma glucose, and A1C levels in patients at high risk for developing type 2 diabetes," said Yehuda Handelsman, MD, FACP, FACE, Medical Director of the Metabolic Institute of America in Tarzana, Calif. and investigator of the study.  "The evaluation of Welchol in this high risk population underscores recent guidelines established by AACE, which recommended physicians target and treat underlying disorders such as high cholesterol and elevated glucose levels in people with prediabetes."(3)

Approximately 57 million adults in the U.S. have impaired fasting glucose and/or impaired glucose tolerance, which puts them at a three to 10 times higher risk of developing type 2 diabetes and a 1.5 times greater risk of cardiovascular disease.(3,4,5)  A recent position statement from the American Diabetes Association (ADA) stated that individuals with an A1C level of
'/>"/>

SOURCE Daiichi Sankyo
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the Cypher(R) Sirolimus Drug-Eluting Stent Over the Endeavor(R) Zotarolimus-Eluting Stent
2. Data Presented at ACC/i2 Summit Demonstrate Impressive Long Term Clinical Outcomes in Real World Patients Treated with OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
3. Adamas Pharmaceuticals TCAD Therapy Demonstrates Broad Spectrum Activity Against Susceptible and Resistant Strains of Influenza in Animal Models
4. New Data Demonstrates Abbotts Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition
5. New Study Demonstrates Safety of Balloon Sinuplasty(TM) Technology in Pediatric Patients Suffering From Chronic Sinusitis
6. Tobiras Next-Generation Once-Daily CCR5 Receptor Antagonist Demonstrates Efficacy, Safety and Tolerability in Treatment-Experienced Patients With HIV
7. NovaShunt Starts its Pivotal Clinical Study "PIONEER" to Demonstrate the Clinical Value of the AFS System
8. Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR
9. Elekta Expands Consultative Services Program to Help MOSAIQ Customers Demonstrate Meaningful Use Guidelines
10. AsepticSure(TM) Hospital Sterilization System Demonstrates Total Eradication of Super Bugs
11. Clinical Data Presented at Asia PCR/Sing LIVE Demonstrate Benefits of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) in Challenging Patient Subsets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... SEOUL, South Korea , Aug. 28, 2015 /PRNewswire/ ... Chungbuk National University and Dr. Ra from Biostar ... , Confirmed 30% increase of lifespan through multiple ... cognitive function, physical vitality, and life expectancy found ... Researchers in Korea have determined the possibility that adult ...
(Date:8/27/2015)... , Aug. 27, 2015  The Academy of ... and Drug Administration,s (FDA,s) draft guidance and proposed ... and biosimilars, to bear a nonproprietary name with ... been seeking a decision from the FDA on ... health care stakeholders urging the agency to use ...
(Date:8/27/2015)... -- According to a new market research report "Medical ... Bariatric ), Material (Nylon, Padded, Canvas), Usage Type (Disposable, Reusable), End ... the Medical Lifting Sling Market is poised to reach USD 706.0 ... CAGR of 11.4 % from 2015 to 2020. ... T ables and 65 F ...
Breaking Medicine Technology:Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4
... 2011 Hurricane Irene came rushing up the East Coast as ... the United States, many states in the Northeast began to worry. ... to hurricanes. Coastal towns from New Jersey all the way up ... York City was one that took steps that had not been ...
... DIEGO, Aug. 30, 2011 ADVENTRX Pharmaceuticals, Inc. (NYSE ... on its planned meetings with the U.S. Food and ... Exelbine (vinorelbine injectable emulsion) Type ... is to discuss the complete response letter regarding the ...
Cached Medicine Technology:Hospitals Evacuated in Preparation for Hurricane Irene with Aid of Pulse Oximeter 2ADVENTRX Provides Update on All Three Pipeline Products 2ADVENTRX Provides Update on All Three Pipeline Products 3ADVENTRX Provides Update on All Three Pipeline Products 4
(Date:8/28/2015)... ... August 28, 2015 , ... Medical Solutions, one of the nation’s largest travel ... in Healthcare by Modern Healthcare and will be honored at an awards dinner ... year, the Best Places to Work in Healthcare program recognizes outstanding employers in the ...
(Date:8/28/2015)... ... ... The Quatela Center for Plastic Surgery is excited to bring patients the ground ... the Food and Drug Administration to eliminate submental fat, also known as the double ... among the premier cosmetic surgeons in Rochester to offer this innovative procedure.     , Developed ...
(Date:8/28/2015)... ... 2015 , ... The Louis W. Sullivan Institute for ... transform quality and efficiency of healthcare delivery worldwide, announced the release of a ... being publicly shared to document progress and inform policy in a report issued ...
(Date:8/28/2015)... ... August 28, 2015 , ... External Counterpulsation, also known as ECP ... now selling External Counterpulsation (EECP or ECP) machines with a full clinic licence to ... in business since 2007 helping people prevent and reverse heart disease through ...
(Date:8/28/2015)... ... August 28, 2015 , ... Super-Sod launched their new website this ... most notable change is the responsive web design. Website users will now have an ... submit quote requests for sod, sign-up for the monthly turf-tips email, and find a ...
Breaking Medicine News(10 mins):Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 3Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3Health News:WEDI's The Sullivan Institute for Healthcare Innovation Releases Gaps in Care Survey 2Health News:Buy New External Counterpulsation (EECP or ECP) With Heart Fit Clinic 2
... a biological sciences major, earned first place at ... a poster presentation about proteins in the smooth ... muscle. The presentation was titled, "Modulation of Cardiovascular ... Metabolites." Tri-Beta is the national biological sciences honor ...
... (embargoed until June 11, 2008, 1:00 p.m. ET) Researchers ... Center have found that Smad proteins regulate microRNA (miRNA) ... to investigate abnormal miRNA processing which is a contributing ... study was published online today in Nature . ...
... Patients Model Top Designers Summer Ware on the ... Makeover Patients To Enjoy "Coming Out in Designer" Party, ... patients of New,York area doctors wearing the world,s top ... surgery fashion show and expo tomorrow,Thursday, June 12th, 2008 ...
... 2008: Systemic lupus erythematosus (SLE) patients with a ... severe disease manifestations, according to new research presented today ... League Against Rheumatism in Paris, France. , According ... is shown to be associated with the relatively milder ...
... YORK, June 11 WallSt.net,s 3-Minute Press Show is ... Shows air Monday through Friday on: http://tv.wallst.net ... with,public company executives on their company and most recent ... insight into a company,s most,recent press release, and its ...
... Outreach Foundation formed to raise awareness and educate ... public on first aid for seizures, ... (AEOF), epilepsyoutreach.org, has joined forces with,Hunter Tylo of CBS, The Bold ... disorders and to educate the public on first-aid,tips for someone experiencing ...
Cached Medicine News:Health News:Need microRNA processing? Get Smad 2Health News:Lupus more severe in patients with Southern European ancestry 2Health News:[video] WallSt.net's '3 Minute Press Show' Features Executive Interviews and Highlights Recent Press for the Following: IUSA, IFUE, FEED, RXEI, GMPM, CRCUF, CVSC, GNMT 2Health News:[video] WallSt.net's '3 Minute Press Show' Features Executive Interviews and Highlights Recent Press for the Following: IUSA, IFUE, FEED, RXEI, GMPM, CRCUF, CVSC, GNMT 3Health News:Hunter Tylo of CBS' The Bold and The Beautiful Joins Forces With the American Epilepsy Outreach Foundation in Public Awareness Campaign 2Health News:Hunter Tylo of CBS' The Bold and The Beautiful Joins Forces With the American Epilepsy Outreach Foundation in Public Awareness Campaign 3
... A fixed pipette is ... a single volume. Fixed volume ... and advantages as other Finnpipette ... design, Super blow-out (1-40ul), Soft-touch ...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... Finnpipette Focus from Thermo Labsystems ... ergonomics with uncompromising performance. ... offers a custom fit for ... shorter tip cones allow easier ...
... A fixed pipette is ... a single volume. Fixed volume ... and advantages as other Finnpipette ... design, Super blow-out (1-40ul), Soft-touch ...
Medicine Products: